Detalhe da pesquisa
1.
Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4).
Ann Oncol
; 30(2): 250-258, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30566590
2.
Randomized phase III and extension studies: efficacy and impacts on quality of life of naldemedine in subjects with opioid-induced constipation and cancer.
Ann Oncol
; 29(6): 1461-1467, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32151367
3.
Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300.
Ann Oncol
; 29(10): 2052-2060, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30052729
4.
A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer.
Ann Oncol
; 27(3): 502-8, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26681680
5.
Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G).
Ann Oncol
; 27(8): 1539-46, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27177863
6.
Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS).
Ann Oncol
; 26(10): 2097-101, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26216386
7.
S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial).
Ann Oncol
; 25(9): 1743-1749, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24942277
8.
The effect of CYP2C19 polymorphism on the safety, tolerability, and pharmacokinetics of tivantinib (ARQ 197): results from a phase I trial in advanced solid tumors.
Ann Oncol
; 24(6): 1653-9, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23413279
9.
Impact of excision repair cross-complementing gene 1 (ERCC1) on the outcomes of patients with advanced gastric cancer: correlative study in Japan Clinical Oncology Group Trial JCOG9912.
Ann Oncol
; 24(10): 2560-2565, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23884439
10.
Phase I study of TAS-102 treatment in Japanese patients with advanced solid tumours.
Br J Cancer
; 107(3): 429-34, 2012 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-22735906
11.
Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial.
Br J Cancer
; 106(7): 1268-73, 2012 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-22415232
12.
Identification of a FGFR3-TACC3 fusion in esophageal cancer.
Ann Oncol
; 28(2): 437-438, 2017 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27771611
13.
A phase II study to explore biomarkers for the use of mFOLFOX6/XELOX plus bevacizumab as a first-line chemotherapy in patients with metastatic colorectal cancer (WJOG7612GTR).
ESMO Open
; 7(6): 100592, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36502778
14.
S-1 and oxaliplatin versus tegafur-uracil and leucovorin as post-operative adjuvant chemotherapy in patients with high-risk stage III colon cancer: updated 5-year survival of the phase III ACTS-CC 02 trial.
ESMO Open
; 6(2): 100077, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33714860
15.
Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study).
Ann Oncol
; 21(5): 1001-5, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19875759
16.
Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer.
Ann Oncol
; 21(4): 766-771, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19828562
17.
Impact of hemoglobin level on survival in definitive chemoradiotherapy for T4/M1 lymph node esophageal cancer.
Dis Esophagus
; 21(3): 195-200, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18430098
18.
Updated results from GEST study: a randomized, three-arm phase III study for advanced pancreatic cancer.
J Cancer Res Clin Oncol
; 143(6): 1053-1059, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28210843
19.
Suppression of T-lymphoma cell apoptosis by monoclonal antibodies raised against cell surface adhesion molecules.
Cancer Res
; 53(20): 5022-7, 1993 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-8402694
20.
Inter-institutional heterogeneity in outcomes of chemotherapy for metastatic gastric cancer: correlative study in the JCOG9912 phase III trial.
ESMO Open
; 1(1): e000031, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27843586